Abstract
The present paper describes the effects of repeated administration of rabbit anti-mouse lymphocyte serum (ALS) or normal rabbit serum (NRS) on tumours induced in Charles-River mice by 7,12-dimethylbenz(α)anthracene (DMBA) given at birth. ALS or NRS were given either at the time of DMBA administration and subsequently at weekly intervals for the first 10 weeks of life, or at daily intervals for 7 days during the first, second, third or fourth week of life. The incidence and histology of the tumours were studied. It was found that treatment of very young mice with ALS greatly reduced the mean survival time of mice and significantly increased the incidence of malignant lymphoma. The incidence of lung tumours was found to be significantly increased in the animals injected with ALS during the second week of life.
Treatment with ALS in the other experimental groups gave results essentially similar to those observed in DMBA control and NRS treated mice.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allison A. C., Berman L. D., Levey R. H. Increased tumour induction by adenovirus type 12 in thymectomized mice and mice treated with anti-lymphocyte serum. Nature. 1967 Jul 8;215(5097):185–187. doi: 10.1038/215185a0. [DOI] [PubMed] [Google Scholar]
- Allison A. C. Tumour development following immunosuppression. Proc R Soc Med. 1970 Oct;63(10):1077–1080. doi: 10.1177/003591577006301055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Balner H., Dersjant H. Increased oncogenic effect of methylcholanthrene after treatment with anti-lymphocyte serum. Nature. 1969 Oct 25;224(5217):376–378. doi: 10.1038/224376a0. [DOI] [PubMed] [Google Scholar]
- Baroni C. D., Kimball J. W., Ward E. N., Wagar R. D. A histological and immunological study of the effect of rabbit anti-mouse lymphocyte serum in BALB-c mice. Transplantation. 1969 May;7(5):303–314. doi: 10.1097/00007890-196905000-00001. [DOI] [PubMed] [Google Scholar]
- Baroni C. D., Mingazzini P., Pesando P., Cavallero A., Uccini S., Scelsi R. Effetti di un'unica dose di siero antilinfocitico sui tumori indotti nel topo dal 7,12-dimentilbenz(a)antracene iniettato alla nascita. Tumori. 1972 Nov-Dec;58(6):397–408. doi: 10.1177/030089167205800605. [DOI] [PubMed] [Google Scholar]
- Burstein N. A., Allison A. C. Effect of antilymphocytic serum on the appearance of reticular neoplasms in SJL-J mice. Nature. 1970 Mar 21;225(5238):1139–1140. doi: 10.1038/2251139a0. [DOI] [PubMed] [Google Scholar]
- Fisher E. R., Soliman O., Fisher B. Effect of antilymphocyte serum on parameters of growth of MCA-induced tumours. Nature. 1969 Jan 18;221(5177):287–288. doi: 10.1038/221287a0. [DOI] [PubMed] [Google Scholar]
- Hirsch M. S., Murphy F. A. Effects of anti-thymocyte serum on Rauscher virus infection of mice. Nature. 1968 May 4;218(5140):478–479. doi: 10.1038/218478a0. [DOI] [PubMed] [Google Scholar]
- Rabbat A. G., Jeejeebhoy H. F. Heterologous antilymphocyte serum (ALS) hastens the appearance of methylcholanthrene-induced tumours in mice. Transplantation. 1970 Feb;9(2):164–166. [PubMed] [Google Scholar]
- Taylor R. B. Immune paralysis of thymus cells by bovine serum albumin. Nature. 1968 Nov 9;220(5167):611–611. doi: 10.1038/220611a0. [DOI] [PubMed] [Google Scholar]
- Vandeputte M. Antilymphocytic serum and polyoma oncogenesis in rats. Transplant Proc. 1969 Mar;1(1):100–105. [PubMed] [Google Scholar]
- Wagner J. L., Haughton G. Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice. J Natl Cancer Inst. 1971 Jan;46(1):1–10. [PubMed] [Google Scholar]
- Woods D. A. Influence of antilymphocyte serum on DMBA induction of oral carcinomas. Nature. 1969 Oct 18;224(5216):276–277. doi: 10.1038/224276a0. [DOI] [PubMed] [Google Scholar]
